U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07617740) titled 'IASO207 Injection for Active Refractory Systemic Lupus Erythematosus (SLE)' on May 01.
Brief Summary: This is a single-center, open-label, exploratory clinical study designed to evaluate the efficacy and safety of IASO207 Injection (in vivo CAR-T) in patients with active refractory systemic lupus erythematosus.
Study Start Date: May 25
Study Type: INTERVENTIONAL
Condition:
REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
Intervention:
DRUG: IASO207 Injection
IASO207 is a third-generation replication-deficient self-inactivating lentiviral vector that carries the gene encoding a second-generation anti-human CD19 chimeric antigen receptor...